Syschem’s board approves Rs 14 crore plant expansion

02 Feb 2026 Evaluate

Syschem (India) has secured its board’s approval for expansion of its existing plant units. The expansion includes the addition of a new manufacturing unit for Amoxicillin and Ampicillin, along with further expansion of the existing CDF unit comprising Cloxacillin Sodium, Dicloxacillin Sodium, and Flucloxacillin Sodium. Additionally, the company will expand its Effluent Treatment Plant (ETP) and Multi-Effect Evaporator (MEE) to strengthen environmental compliance and support sustainable operations.

This expansion is expected to significantly enhance the company’s manufacturing capacity, operational efficiency, and environmental management capabilities. The estimated investment required for the expansion is around Rs 14 crore and the expanded capacities are expected to be commissioned by December, 2026.

Syschem (India) is engaged in manufacturing pesticides' namely Monocrotophos (MCP) and Dichlorvos (DDVP).

Syschem (India) Share Price

50.37 -0.59 (-1.16%)
25-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.45
Dr. Reddys Lab 1305.50
Cipla 1348.55
Zydus Lifesciences 919.40
Lupin 2292.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×